GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuso Pharmaceutical Industries Ltd (TSE:4538) » Definitions » Equity-to-Asset

Fuso Pharmaceutical Industries (TSE:4538) Equity-to-Asset : 0.50 (As of Sep. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Fuso Pharmaceutical Industries Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Fuso Pharmaceutical Industries's Total Stockholders Equity for the quarter that ended in Sep. 2024 was 円37,900 Mil. Fuso Pharmaceutical Industries's Total Assets for the quarter that ended in Sep. 2024 was 円75,999 Mil.

The historical rank and industry rank for Fuso Pharmaceutical Industries's Equity-to-Asset or its related term are showing as below:

TSE:4538' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.45   Med: 0.47   Max: 0.5
Current: 0.5

During the past 13 years, the highest Equity to Asset Ratio of Fuso Pharmaceutical Industries was 0.50. The lowest was 0.45. And the median was 0.47.

TSE:4538's Equity-to-Asset is ranked worse than
62.93% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs TSE:4538: 0.50

Fuso Pharmaceutical Industries Equity-to-Asset Historical Data

The historical data trend for Fuso Pharmaceutical Industries's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuso Pharmaceutical Industries Equity-to-Asset Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.48 0.50 0.49 0.48

Fuso Pharmaceutical Industries Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.47 0.46 0.48 0.50

Competitive Comparison of Fuso Pharmaceutical Industries's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuso Pharmaceutical Industries's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Fuso Pharmaceutical Industries's Equity-to-Asset falls into.


;
;

Fuso Pharmaceutical Industries Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Fuso Pharmaceutical Industries's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=36661/75802
=0.48

Fuso Pharmaceutical Industries's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=37900/75999
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuso Pharmaceutical Industries  (TSE:4538) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Fuso Pharmaceutical Industries Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Fuso Pharmaceutical Industries's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuso Pharmaceutical Industries Business Description

Traded in Other Exchanges
N/A
Address
No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid.

Fuso Pharmaceutical Industries Headlines

No Headlines